Evidence map›Paper›PMID 40052608›Full record

ArticleThe Journal of urology2025

Reply by Authors.

Gregory E Tasian, Jonathan D Harper, Hussein R Al-Khalidi, Hongqiu Yang, Naim M Maalouf, Michele Curatolo, H Henry Lai, Alana Desai, Jodi A Antonelli, Jing Huang and 5 more

Abstract read
In one paragraph

Article in The Journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gregory E TasianDepartment of Surgery, Division of Urology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Jonathan D HarperDepartment of Urology, University of Washington, Seattle, Washington.
Hussein R Al-KhalidiDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Hongqiu YangDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Naim M MaaloufDepartment of Internal Medicine and Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, Texas.
Michele CuratoloDepartment of Anesthesiology & Pain Medicine, University of Washington, Seattle, Washington.
H Henry LaiDepartment of Surgery (Urology), Washington University in St Louis, St Louis, Missouri.
Alana DesaiDepartment of Surgery (Urology), Washington University in St Louis, St Louis, Missouri.
Jodi A AntonelliDepartment of Urology, Duke University School of Medicine, Durham, North Carolina.
Jing HuangDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Justin B ZiembaDepartment of Urology, University of Pennsylvania, Philadelphia, Pennsylvania.
Hunter WessellsDepartment of Urology, University of Washington, Seattle, Washington.
Ziya KirkaliNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Charles D ScalesDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-7887-0204
Peter P ReeseDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

Urinary Stone Disease Research Network: Scientific Data Research CenterU01DK110988 · NIDDK · DUKE UNIVERSITY · PI AL-KHALIDI, HUSSEIN, SCALES, CHARLES D · 2016 to 2020
$6.9M
Optimizing Fluid Therapy and Stent Management in Children and Adults with NephrolithiasisU01DK110994 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MAALOUF, NAIM M · 2016 to 2024
$5.3M
Harnessing Behavior to Decrease Urinary Stone Disease Morbidity Research ProjectU01DK110961 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI REESE, PETER PHILIP, TASIAN, GREGORY EDWARD · 2016 to 2024
$5.3M
Extension of Urinary Stone Disease Research Network (USDRN) at Washington UniversityU01DK110986 · NIDDK · WASHINGTON UNIVERSITY · PI LAI, HING HUNG HENRY · 2016 to 2024
$5.2M
UW USDRN Clinical CenterU01DK110954 · NIDDK · UNIVERSITY OF WASHINGTON · PI HARPER, JONATHAN D., WESSELLS, HUNTER · 2016 to 2024
$4.9M
Urinary Stone Disease Research Network: Scientific Data Research CenterU24DK110988 · NIDDK · DUKE UNIVERSITY · PI AL-KHALIDI, HUSSEIN, SCALES, CHARLES D · 2022 to 2024
$4.1M
NIDDK NIH HHS U01 DK110954NIDDK NIH HHS U01 DK110961NIDDK NIH HHS U01 DK110986NIDDK NIH HHS U01 DK110988NIDDK NIH HHS U01 DK110994NIDDK NIH HHS U24 DK110988
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40052608
PMCPMC12331241

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.